LiSheng Chu - PharmaEngine Independent Director
4162 Stock | TWD 96.80 0.30 0.31% |
Director
Mr. Frank LiSheng Chu was serving as Independent Director in PharmaEngine, Inc. since June 20, 2013. He holds a Master degree in Commerce from National Taiwan University. He is also Independent Director in Yue Yuen Industrial Limited and WELLPOOL CO., Ltd. since 2013.
Tenure | 11 years |
Phone | 886 2 2515 8228 |
Web | https://www.pharmaengine.com |
PharmaEngine Management Efficiency
The company has return on total asset (ROA) of 0.0589 % which means that it generated a profit of $0.0589 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0985 %, meaning that it generated $0.0985 on every $100 dollars invested by stockholders. PharmaEngine's management efficiency ratios could be used to measure how well PharmaEngine manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
Yizong Zhang | San Fu Chemical | N/A | |
Boxi Liao | Goldsun Building Materials | N/A | |
Honglong Huang | Phoenix Silicon International | N/A | |
Guofeng Lin | Phoenix Silicon International | N/A | |
Yingwen Zhan | Goldsun Building Materials | N/A | |
Huaikun Yang | Eternal Materials Co | N/A | |
Shizong Zhang | Goldsun Building Materials | N/A | |
Chunmei Lin | Goldsun Building Materials | N/A | |
Shundi Hong | Chinese Maritime Transport | N/A | |
Guoyuan Liang | San Fu Chemical | N/A | |
Jianqiang Wu | Goldsun Building Materials | N/A | |
Shirong Zhan | Grand Plastic Technology | N/A | |
Taihong Lin | Goldsun Building Materials | N/A | |
Youmei He | Grand Plastic Technology | N/A | |
Hongrong Gao | Qualipoly Chemical Corp | N/A | |
Yaoming Wang | San Fu Chemical | N/A | |
Tianling Zhu | Chinese Maritime Transport | N/A | |
Wenliang Zeng | Qualipoly Chemical Corp | N/A | |
Mingji Zhang | Goldsun Building Materials | N/A | |
Qide Hong | Goldsun Building Materials | N/A | |
Chongyi Jiang | Grand Plastic Technology | N/A |
Management Performance
Return On Equity | 0.0985 | |||
Return On Asset | 0.0589 |
PharmaEngine Leadership Team
Elected by the shareholders, the PharmaEngine's board of directors comprises two types of representatives: PharmaEngine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PharmaEngine. The board's role is to monitor PharmaEngine's management team and ensure that shareholders' interests are well served. PharmaEngine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PharmaEngine's outside directors are responsible for providing unbiased perspectives on the board's policies.
Xiuji Zhang, Director | ||
Lin C, Director | ||
PoWu Gean, Director | ||
Changjing Ye, CEO, General Manager, Director | ||
HongRen Wang, Pres CEO | ||
Yusheng Zhao, Director | ||
LiSheng Chu, Independent Director | ||
Fuxiu Yin, Independent Director | ||
Guocai Pan, Director | ||
Yuqing Su, Independent Director | ||
ChiHsing Chang, VP Devel | ||
Kunhong Lai, Independent Director | ||
Chuan Lin, Director | ||
YuFang Hu, General Manager | ||
Bowu Jian, Director | ||
Qiying Huang, Director | ||
Jinrong Lin, Director | ||
Jeffrey Suen, Chairman of the Board | ||
Peter Wu, Director Sales | ||
Junhui He, Chairman of the Board | ||
Quan Lin, Director | ||
Zhili Wang, Independent Director | ||
C Chang, Deputy General Manager-Finance & Administration | ||
Kangji Zhou, Independent Director | ||
Hubert Chan, Deputy General Manager-Clinical & Regulatory Affairs | ||
KangChi Chou, Independent Director | ||
Melody Lin, Director HR | ||
Lizhen Lin, Director | ||
Li Lin, Director | ||
Qixing Zhang, Senior Head-Finance and Administration Management | ||
WenHwa Chang, Director | ||
Ruiwen Wu, Director | ||
Yihui Lin, Director | ||
Jose Hsieh, Sr Accounting | ||
Zhaosheng Wu, Deputy Head of Development Department | ||
FuShiow Yin, Independent Director | ||
Huai Wang, Independent Director | ||
Grace Yeh, CEO, General Manager, Director | ||
Qixiang Chen, Director | ||
MingThau Sheu, Director | ||
Xinyi Lin, Director |
PharmaEngine Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PharmaEngine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0985 | |||
Return On Asset | 0.0589 | |||
Profit Margin | 0.54 % | |||
Operating Margin | 0.53 % | |||
Current Valuation | 14.42 B | |||
Shares Outstanding | 143.69 M | |||
Shares Owned By Insiders | 22.57 % | |||
Shares Owned By Institutions | 20.72 % | |||
Price To Book | 4.72 X | |||
Price To Sales | 24.13 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PharmaEngine in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PharmaEngine's short interest history, or implied volatility extrapolated from PharmaEngine options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in PharmaEngine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for PharmaEngine Stock analysis
When running PharmaEngine's price analysis, check to measure PharmaEngine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaEngine is operating at the current time. Most of PharmaEngine's value examination focuses on studying past and present price action to predict the probability of PharmaEngine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaEngine's price. Additionally, you may evaluate how the addition of PharmaEngine to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |